US

Ad tech company Madup picks up Series B funding

South Korea-based Madup, an ad tech company, has secured 13.4 billion (almost $12 million) in Series B funding. The investors were Praxis Capital, Stonebridge Ventures, ID ventures, MG investment and Seoul Investment Partners.

Grabango nabs $12 mln Series A

Silicon Valley-based Grabango, a provider of checkout-free shopping technology for existing store, has raised $12 million in Series A financing. Propel Venture Partners led the round with participation from Ridge Ventures, Abstract Ventures, Commerce Ventures and Founders Fund. In addition to the funding, Ryan Gilbert, a general partner at Propel, will join Grabango’s board of directors.

Frequency Therapeutics scores $42 mln Series B

Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company, has raised $42 million in Series B financing. Taiwania Capital Management and Axil Capital led the round with participation from Yonjin Capital, DF Investments, Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital.

Atlantic Therapeutics snags Series B funding

Atlantic Therapeutics, a medical technology company focused on treating bladder leaks, has secured 28 million euros in Series B funding. LSP led the round with participation from other investors that included Andera Partners, Atlantic Bridge Ventures, Seroba Life Sciences and Earlybird Venture Capital.

Aerospace startup Boom Supersonic gathers $100 mln Series B

Denver-based Boom Supersonic, an aerospace startup, has raised $100 million in Series B funding. The investors included Sunstone Management and Y Combinator Continuity.

Tusk Ventures to raise $70 mln second venture-capital fund

Tusk Ventures has set out to raise a $70 million second venture-capital fund, according to a filing with the SEC.

Third Kind Venture Capital targets $65 mln for sophomore fund

Third Kind Venture Capital is seeking to raise $65 million for its second fund, according to an SEC filing. The New York-based venture firm is focused on early-stage investments.

Qualcomm Ventures backs Baicells

Plano, Texas-based Baicells, a small cell technology company, has secured an undisclosed amount of funding. The investor was Qualcomm Ventures LLC.

Medication guidance company WithMe Health rakes in $20 mln

Boston-based WithMe Health, a medication guidance company, has raised $20 million in financing. The investor was Oak HC/FT.

Pear Therapeutics locks in $64 mln Series C

Boston and San Francisco-based Pear Therapeutics, a provider of prescription digital therapeutics, has secured $64 million in Series C financing. Temasek led the round with participation from other investors that included Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative, EDBI, Blue Water Life Science Fund LP and Trustbridge Partners.